TransCode Therapeutics (NASDAQ:RNAZ) reported quarterly losses of $(0.20) per share. This is a 33.33 percent increase over losses of $(0.30) per share from the same period last year.
GameStop Completes At-The-Market Equity Offering Program; Will Use Proceeds For ‘general corporate purposes as well as for investing in growth initiatives and maintaining a strong balance sheet.’
GameStop Corp. (NYSE:GME) (“GameStop” or the “Company”) today announced that it has completed its previously announced “at-the-market” equity offering program (the “ATM
